Pulsenmore Completes CE Registration for Home Fertility Ultrasound System

Pulsenmore said it completed CE registration in Europe for a home ultrasound system designed for follicular monitoring, expanding the Israeli medical-device company into fertility care. The regulatory milestone covers the system’s intended European use for tracking follicle development at home; the filing did not describe a commercial launch or report revenue, adoption or clinical-performance results. Pulsenmore disclosed the development through the Tel Aviv Stock Exchange at 14:12 Israel time. Chief Financial Officer Eran Hirsh signed the filing for Pulsenmore Ltd., which is based in Omer.